1.Arpinati M，Tolomelli G，Bochicchio MT，et al. Molecular Monitoring of BCR-ABL Transcripts after Allogeneic Stem Cell Transplantation for Chronic Myeloid Leukemia. Biol Blood Marrow Transplant，2013，19：735-740.

2.Bassan R，Spinelli O，Oldani E，et al. Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease（MRD）in adult acute lymphoblastic leukemia（ALL）. Blood，2009，113：4153-4162.

3.Chen H，Liu KY，Xu LP，et al. Administration of imatinib after allogeneic hematopoietic stem cell transplantation may improve disease-free survival for patients with Philadelphia chromosome-positive acute lymphobla stic leukemia. J Hematol Oncol，2012，5：29.

4.Elorza I，Palacio C，Dapena JL，et al. Relationship between minimal residual disease measured by multiparametric flow cytometry prior to allogeneic hematopoietic stem cell transplantation and outcome in children with acute lymphoblastic leukemia. Haematologica，2010，95：936-941.

5.Huang XJ，Xu LP，Liu KY，et al. Individualized intervention guided by BCR-ABL transcript levels after HLA-identical sibling donor transplantation improves HSCT outcomes for patients with chronic myeloid leukemia. Biol Blood Marrow Transplant，2011，17：649-656.

6.Jacobsohn DA，Tse WT，Chaleff S，et al. High WT1 gene expression before haematopoietic stem cell transplant in children with acute myeloid leukaemia predicts poor event-free survival. Brit J Haematol，2009，146：669-674.

7.Kaeda J，O’Shea D，Szydlo RM，et al. Serial measurement of BCR-ABL transcripts in the peripheral blood after allogeneic stem cell transplantation for chronic myeloid leukemia：an attempt to define patients who may not require further therapy. Blood，2006，107：4171-4176.

8.Nagafuji K，Miyamoto T，Eto T，et al. Monitoring of minimal residual disease（MRD）is useful to predict prognosis of adult patients with Ph-negative ALL：results of a prospective study（ALL MRD2002 Study）. J Hematol Oncol，2013，6：14.

9.Walter RB，Gooley TA，Wood BL，et al. Impact of pretransplantation minimal residual disease，as detected by multiparametric flow cytometry，on outcome of myeloablative hematopoietic cell transplantation for acute myeloid leukemia. J Clin Oncol，2011，29：1190-1197.

10.Yan CH，Liu DH，Liu KY et al. Risk stratification-directed donor lymphocyte infusion could reduce relapse of standard-risk acute leukemia patients after allogeneic hematopoietic stem cell transplantation. Blood，2012，119：3256-3262.